Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-20

Clinical Trial Update: A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics [NA]

View source ↗

Summary

The trial update shows that the feasibility study evaluating Harmony 1 Sensors for adults and children with Type 1 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Harmony 1 Sensors

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes | NA | Status: WITHDRAWN